Korro Bio, Inc. (NASDAQ:KRRO) Receives Consensus Recommendation of “Buy” from Analysts
Korro Bio, Inc. (NASDAQ:KRRO – Get Free Report) has received a consensus rating of “Buy” from the seven research firms that are currently covering the firm, MarketBeat.com reports. Five investment analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month price target […]
Korro Bio, Inc. (NASDAQ:KRRO – Get Free Report) has received a consensus rating of “Buy” from the seven research firms that are currently covering the firm, MarketBeat.com reports. Five investment analysts have rated the stock with a buy recommendation and two have issued a strong buy recommendation on the company. The average 12-month price target […]
